CDK13-related disorder: Report of a series of 18 previously unpublished individuals and description of an epigenetic signature

Archive ouverte

Rouxel, Flavien | Relator, Raissa | Kerkhof, Jennifer | Mcconkey, Haley | Levy, Michael | Dias, Patricia | Barat-Houari, Mouna | Bednarek, Nathalie | Boute, Odile | Chatron, Nicolas | Cherik, Florian | Delahaye-Duriez, Andrée | Doco-Fenzy, Martine | Faivre, Laurence | Gauthier, Lucas, W. | Heron, Delphine | Hildebrand, Michael | Lesca, Gaëtan | Lespinasse, James | Mazel, Benoit | Menke, Leonie | Morgan, Angela | Pinson, Lucile | Quelin, Chloe | Rossi, Massimiliano | Ruiz-Pallares, Nathalie | Tran Mau-Them, Frédéric | van Kessel, Imke | Vincent, Marie | Weber, Mathys | Willems, Marjolaine | Leguyader, Gwenael | Sadikovic, Bekim | Genevieve, David

Edité par CCSD ; Nature Publishing Group -

International audience. Purpose: Rare genetic variants in CDK13 are responsible for CDK13-related disorder (CDK13-RD), with main clinical features being developmental delay or intellectual disability, facial features, behavioral problems, congenital heart defect, and seizures. In this paper, we report 18 novel individuals with CDK13-RD and provide characterization of genome-wide DNA methylation.Methods: We obtained clinical phenotype and neuropsychological data for 18 and 10 individuals, respectively, and compared this series with the literature. We also compared peripheral blood DNA methylation profiles in individuals with CDK13-RD, controls, and other neurodevelopmental disorders episignatures. Finally, we developed a support vector machine-based classifier distinguishing CDK13-RD and non-CDK13-RD samples.Results: We reported health and developmental parameters, clinical data, and neuropsychological profile of individuals with CDK13-RD. Genome-wide differential methylation analysis revealed a global hypomethylated profile in individuals with CDK13-RD in a highly sensitive and specific model that could aid in reclassifying variants of uncertain significance.Conclusion: We describe the novel features such as anxiety disorder, cryptorchidism, and disrupted sleep in CDK13-RD. We define a CDK13-RD DNA methylation episignature as a diagnostic tool and a defining functional feature of the evolving clinical presentation of this disorder. We also show overlap of the CDK13 DNA methylation profile in an individual with a functionally and clinically related CCNK-related disorder.

Suggestions

Du même auteur

Functional correlation of genome‐wide DNA methylation profiles in genetic neurodevelopmental disorders

Archive ouverte | Levy, Michael | CCSD

International audience. An expanding range of genetic syndromes are characterized by genome-wide disruptions in DNA methylation profiles referred to as episignatures. Episignatures are distinct, highly sensitive, an...

Clinico-biological refinement of BCL11B-related disorder and identification of an episignature: A series of 20 unreported individuals

Archive ouverte | Sabbagh, Quentin | CCSD

International audience. Purpose: BCL11B-related disorder (BCL11B-RD) arises from rare genetic variants within the BCL11B gene, resulting in a distinctive clinical spectrum encompassing syndromic neurodevelopmental d...

DNA methylation episignature in Gabriele-de Vries syndrome

Archive ouverte | Cherik, Florian | CCSD

International audience. PURPOSE: Gabriele-de Vries syndrome (GADEVS) is a rare genetic disorder characterized by developmental delay and/or intellectual disability, hypotonia, feeding difficulties, and distinct faci...

Chargement des enrichissements...